Verrica Pharmaceuticals (VRCA) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.26
-0.92
-0.58
-0.24

Details

Expected EPS
-1.261667
Actual EPS
-1
Surprise EPS
0.26
Surprise Percent
+20.74%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -1 per share for Q2 2025.

0 Comments

Share your thoughts